Revolution Medicines RVMDW
NASDAQ RVMDW
$9.68 +0.15 (+1.51%)
As of: Oct 29, 2026 · 1:02 PM EDT

Revolution Medicines (RVMDW) EBIT (2019 - 2026)

Updated

Revolution Medicines (RVMDW) recorded EBIT of -$505.13 million in Q2 2026, compared with -$264.71 million a year earlier.

Analysis

Revolution Medicines (RVMDW) EBIT (2019 - 2026) Analysis & Trends

On a TTM basis, Revolution Medicines' EBIT came in at -$1.63 billion as of Jun 30, 2026; for FY2025, it was -$1.18 billion.

  • Across earlier years, EBIT came in at -$689.52 million in FY2024, -$487.19 million in FY2023, -$258.28 million in FY2022 and -$188.01 million in FY2021.
  • The Q2 2026 figure is the lowest quarterly EBIT in data going back to Q1 2019.
  • Per Business Quant, the preceding three quarters came in at -$445.22 million (Q1 2026), -$361.63 million (Q4 2025) and -$315.27 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -505.13 Mn
Mar 31, 2026 -445.22 Mn
Dec 31, 2025 -361.63 Mn
Sep 30, 2025 -315.27 Mn
Jun 30, 2025 -264.71 Mn
Mar 31, 2025 -240.76 Mn
Dec 31, 2024 -216.31 Mn
Sep 30, 2024 -175.71 Mn
Jun 30, 2024 -156.64 Mn
Mar 31, 2024 -140.86 Mn
Dec 31, 2023 -179.98 Mn
Sep 30, 2023 -123.25 Mn
Jun 30, 2023 -108.80 Mn
Mar 31, 2023 -75.16 Mn
Dec 31, 2022 -61.71 Mn
Sep 30, 2022 -76.53 Mn
Jun 30, 2022 -62.09 Mn
Mar 31, 2022 -57.95 Mn
Dec 31, 2021 -52.91 Mn
Sep 30, 2021 -53.16 Mn
API Access

Revolution Medicines EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=RVMDW&period=max&api_key=YOUR_API_KEY